Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Trading Statement

12 Oct 2007 07:00

Cyprotex PLC12 October 2007 Cyprotex PLC (the "Group" or "Cyprotex") NEWS 12 October 2007 Trading Update : Building Confidence The Director's confidence with Cyprotex's core operations continued to buildduring the third quarter of 2007. The Group enters the final three months ofits year on an optimistic note. Historically the final quarter has been the strongest period of Cyprotex'sfinancial year. Moreover, management is pleased to confirm that its customerbase has continued to expand rapidly. Included within the high number of newMSA (Master Services Agreements) recently signed, and taking the Group's 'activecustomer list' beyond 150 pharmaceutical and biotech companies, are severalinternational majors. Strict confidentiality agreements preclude Cyprotex fromnaming individual clients, but the company can now confirm it is currentlycontracted to work for six out of the world's 'top ten' global pharmaceuticalcompanies. The scale and visibility that strong working relationships with suchpartners are capable of providing, is key to proving Cyprotex's business plan.The management is pleased to report an exceptional level of repeat business,while also being asked to tenders for more long-term contract work as well asproject specific collaborations. Cyprotex presently holds an adequate cash resource whilst also retaining asignificant, unused banking facility. Based on current momentum, managementsees the opportunity for modest cash generation to expand this 'cushion' stillfurther during the final three months of the 2007. For further information: Cyprotex PLCRobert Morrison Atwater, CEORussell Gibbs, CFOTel: +44 (0)1625 505 100ir@cyprotex.comwww.cyprotex.com Numura Code Securities LimitedCharles Walker, Corporate FinanceTel: +44 (0)20 7776 1200cew@nomuracode.comwww.nomuracode.com Media Enquires: WMC CommunicationsSimon MillerTel: +44 (0)20 7930 9030simon.miller@wmccommunications.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Oct 20142:36 pmRNSShare Allotment CLN Final
9th Oct 20147:00 amRNSExpansion of Drug Transporter Capabilities
1st Oct 20147:00 amRNSExpansion of Toxicology Capabilities
9th Sep 20147:00 amRNSLaunch of KeratinoSensTM Service
4th Sep 20147:00 amRNSCyprotex joins CiPA initiative
29th Aug 20144:28 pmRNSListing of Loan Notes on Cayman Stock Exchange
28th Aug 20147:00 amRNSInterim Results 2014
21st Aug 20147:00 amRNSListing of Loan Notes on Cayman Stock Exchange
14th Aug 20143:30 pmRNSHolding(s) in Company
24th Jul 201412:15 pmRNSResult of AGM, GM & Further re Share Consolidation
3rd Jul 20147:00 amRNSProposed Share Consolidation & Notice of GM
1st Jul 20147:00 amRNSExpansion of Bioanalytical Capabilities
4th Jun 201411:44 amRNSDirector/PDMR Shareholding
16th Apr 201411:31 amRNSGrant of Options
25th Mar 20147:00 amRNSFinal Results
13th Mar 20144:57 pmRNSHolding(s) in Company
28th Jan 201410:46 amRNSGrant Options
28th Jan 201410:15 amRNSgrant of options
27th Jan 20144:52 pmRNSHolding(s) in Company
27th Jan 20144:19 pmRNSHolding(s) in Company
23rd Jan 20147:01 amRNSExecutive option scheme
23rd Jan 20147:00 amRNSTrading Update
2nd Jan 20147:00 amRNSAcquisition of CeeTox
19th Dec 20139:56 amRNSHolding(s) in Company
25th Nov 20139:48 amRNSDirector Dealing
5th Nov 20131:33 pmRNSReplacement: Holding(s) in Company
5th Nov 20139:44 amRNSHolding(s) in Company
5th Nov 20139:36 amRNSHolding(s) in Company
1st Oct 20131:36 pmRNSHolding(s) in Company
30th Sep 201311:43 amRNSHolding(s) in Company
26th Sep 201310:22 amRNSResult of GM & Board changes
3rd Sep 20137:00 amRNSPublication of Circular
21st Aug 20137:00 amRNSSubscription Agreement
15th Aug 20139:04 amRNSHolding(s) in Company
7th Aug 20137:00 amRNSHalf Yearly Report
24th Jul 20131:39 pmRNSDirectorate Change
18th Jul 20137:00 amRNSLaunch of new eCiphrNeuro service
17th Jul 20133:08 pmRNSResult of AGM
11th Jul 20137:00 amRNSLaunch of New Toxicity Guide
4th Jul 201310:09 amRNSHolding(s) in Company
2nd Jul 20132:09 pmRNSHolding(s) in Company
27th Jun 20134:36 pmRNSDirector/PDMR Shareholding
27th Jun 20132:30 pmRNSHolding(s) in Company
27th Jun 20132:30 pmRNSHolding(s) in Company
27th Jun 20132:30 pmRNSHolding(s) in Company
20th Jun 20137:00 amRNSTrading update
4th Jun 20137:00 amRNSIssue of Equity
21st May 20132:06 pmRNSHolding(s) in Company
21st May 20132:05 pmRNSHolding(s) in Company
1st May 20137:00 amRNSContract with U.S. EPA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.